At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 12 enrolled
Drug / intervention
levodopadrug
Likely dose
levodopa 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dopaminergic Enhancement of Learning and Memory (LL_001, Project on Aphasia)
In Brief
A Phase 4 clinical trial evaluating levodopa for Cerebrovascular Accident and Aphasia. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether levodopa, in combination with a high frequency language training, is effective in boosting naming performance in patients with aphasia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCerebrovascular Accident, Aphasia
CountriesGermany
CollaboratorsGerman Federal Ministry of Education and Research
Timeline
Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2005
First PostedFeb 2005
Primary CompletionFeb 2007
Study CompletionDec 2008
TodayJul 2026
First PostedFeb 4, 2005
Enrollment StartJan 1, 2005
Primary CompletionFeb 1, 2007
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 21.4 years ago
Interventions
levodopadrug
100mg levodopa per day over 10 days/ treatment phase